Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MicroPort NeuroScientificHKSE:02172 -1.20%93 ROA % is 8.80% as of Dec. 2025, which is 7% above its 10-year median of 8.24. GuruFocus rates HKSE:02172 with a GF Score™ of 93/100 and a GF Value™ of HK$13.19 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, MicroPort NeuroScientific ranks better than 83.63% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. MicroPort NeuroScientific's annualizedNet Income for the quarter that ended in Dec. 2025 was HK$202.4 Mil.
MicroPort NeuroScientific's average Total Assets over the quarter that ended in Dec. 2025 was HK$2,299.5 Mil. Therefore, MicroPort NeuroScientific's annualized ROA % for the quarter that ended in Dec. 2025 was 8.80%.
The historical rank and industry rank for MicroPort NeuroScientific's ROA % or its related term are showing as below:
HKSE:02172'
s ROA % Range Over the Past 10 Years
Min: -1.32 Med: 8.24 Max: 14.03
Current: 8.97
During the past 7 years, MicroPort NeuroScientific's highest ROA % was 14.03%. The lowest was -1.32%. And the median was 8.24%.
HKSE:02172's ROA % is ranked better than 83.63% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.7
vs HKSE:02172: 8.97
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, MicroPort NeuroScientific's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MicroPort NeuroScientific ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroScientific's ROA % distribution charts can be found below:
* The bar in red indicates where MicroPort NeuroScientific's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
MicroPort NeuroScientific (HKSE:02172) has a ROA % of 8.80% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on MicroPort NeuroScientific and its competitors. This is near median its historical median of 8.24. According to the industry distribution chart, MicroPort NeuroScientific ranks #140 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 16.4%.
Is MicroPort NeuroScientific's ROA % too high?
MicroPort NeuroScientific's current ROA % of 8.80% is near median its 10-year median of 8.24. The Medical Devices & Instruments industry median ROA % is 0.70. MicroPort NeuroScientific's value of 8.80% is 1157.1% above this industry median. Based on the distribution chart, MicroPort NeuroScientific ranks #140 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, MicroPort NeuroScientific has a GF Score™ of 93/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MicroPort NeuroScientific's ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MicroPort NeuroScientific ranks #140 out of 855 companies for ROA %. This places MicroPort NeuroScientific in the top 16% of its industry — outperforming the majority of peers. The industry median ROA % is 0.70. MicroPort NeuroScientific's value of 8.80% is 1157.1% above this benchmark. While the company's 10-year median is 8.24 vs. the industry median of 0.70, MicroPort NeuroScientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.70, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MicroPort NeuroScientific's current ROA % of 8.80% is 1157.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on MicroPort NeuroScientific and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MicroPort NeuroScientific's current ROA % is 8.80%, which is near median its own 10-year median of 8.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort NeuroScientific stock overvalued right now?
Based on GuruFocus' analysis, MicroPort NeuroScientific (HKSE:02172) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.19, compared to a current price of HK$9.02 — trading 31.6% below its estimated fair value. The current ROA % is 8.80%, which is near median its 10-year median of 8.24 and 1157.1% above the Medical Devices & Instruments industry median of 0.70. MicroPort NeuroScientific's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For MicroPort NeuroScientific (HKSE:02172), the current ROA % is 8.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MicroPort NeuroScientific (HKSE:02172) Overvalued in 2026?
Based on GuruFocus' analysis, MicroPort NeuroScientific stock appears to be undervalued.
The current stock price of HK$9.02 is trading 31.6% below its estimated GF Value™ of HK$13.19.
GuruFocus considers MicroPort NeuroScientific to be Possible Value Trap.
Key valuation signals for HKSE:02172:
ROA %: 8.80% (near median its 10-year median of 8.24)
GF Value™: HK$13.19 vs. price of HK$9.02 (31.6% below fair value)
Industry Position: 1157.1% above the Medical Devices & Instruments median (#140 of 855)
No single metric tells the full story. See the HKSE:02172 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MicroPort NeuroScientific Corp is in the neuro-interventional medical device industry, dedicated to providing solutions for physicians and patients. The company boasts a comprehensive portfolio of approved therapeutic products covering all of three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. The company generates almost all of its revenue from the sale of medical devices. Geographically, the company generates the majority of its revenue from the PRC region, and also has operations in Israel.
93GF Score
Get the complete analysis for HKSE:02172
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02172 has been successfully added to your 
